Dow Jones Top Company Headlines at 11 PM ET: University Endowments Are About to Strike It Big on the SpaceX IPO | OpenAI ...
University Endowments Are About to Strike It Big on the SpaceX IPO
Some schools have a tenth or more of their endowments in Elon Musk's rocket company.
----
OpenAI Files to Go Public in Test of Investor Appetite for Top AI Startups
The ChatGPT maker confidentially filed for an offering, but said 'it may be a while' before it goes public
----
U.S. Expands List of Chinese Tech Companies It Says Assist Beijing's Military
Some well-known companies were added to the annually updated list, which designates them as a U.S. national-security risk.
----
Meta Launches 'Workforce Academy' to Train Workers to Build Data Centers
The five-week program, which is free of charge and guarantees a job, follows a recent layoff of 8,000 employees.
----
Apple Unveiled the New Siri AI. Here Are the Key Takeaways.
Apple showed off a new version of its Siri chatbot, technology developed with Google that the iPhone maker hopes will help power a comeback in AI.
----
Perrigo CEO Ousted Over Personal Conduct
Perrigo Chief Executive Patrick Lockwood-Taylor has resigned after the board found his personal conduct had violated company code.
----
Vail Resorts Cuts Outlook Again as Low Snowfall Weighs on Visits
The ski-resort operator said weather conditions remained extremely unfavorable during the recent quarter, weighing on visits and revenue, particularly at Vail's resorts in the Rockies.
----
GoHealth Files for Bankruptcy, Handing Control to Lenders
The insurance brokerage, once valued at $6.6 billion, entered chapter 11 with nearly $1 billion in debt and a plan that leaves operations intact.
----
Amazon Enters Agreement With Corning for Optical Fiber for Data Centers
Amazon.com said it entered a multibillion-dollar agreement with Corning to get optical fiber, cable and connectivity solutions to support its growing data center footprint.
----
Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success
A late-stage trial showed retatrutide was effective in weight loss and in alleviating obesity-linked conditions.
----
Wix.com Slashes 20% of Staff, Lowers Outlook as Restructuring Continues
The website-building and web-services platform said that it is scaling back parts of its business as part of a broader organizational realignment, moves that are expected to weigh on bookings and revenue growth in 2026.
----
Johnson & Johnson to Buy Firefly Bio for $1 Billion
Johnson & Johnson has agreed to buy biotechnology company Firefly Bio for $1 billion in cash in a deal that bolsters the drugmaker's oncology pipeline.
----
Honeywell Backs Full-Year Guidance
Honeywell backed its full-year guidance as it looks to close a spinoff of its aerospace division.
----
Campbell's Sales Fall on Continued Weak Demand for Snacks
Campbell's sales fell in the fiscal third quarter, driven in part by further declines in its snacks business, but said its profit rose.
----
Incyte to Buy Vega Therapeutics For Up to $2 Billion
Incyte has agreed to buy Vega Therapeutics for up to $2 billion in a deal that expands the biopharmaceutical company's hematology portfolio into bleeding disorders.
(END) Dow Jones Newswires
June 08, 2026 23:15 ET (03:15 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
What’s Ahead for Stocks This Quarter—and Where to Invest
Are TIPS ETFs the Best Way to Fight Inflation?
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
10 Best Blue-Chip Stocks to Buy for the Long Term
United States